C-201(Corridor Pharmaceuticals)

N/A

Report date: 2024/10/21 17:35:34
NME

Base Information

Drug NameC-201(Corridor Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArginase 2 inhibitorsArginase-1 inhibitors
TargetsArginase 2Arginase-1
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending
Highest Status in ChinaN/A
Originator CompaniesCorridor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A